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ABSTRACT
Introduction Chronic post-surgical pain (CPSP) after
lung or pleural surgery is a common complication and
associated with a decrease in quality of life, long-term use
of pain medication and substantial economic costs. An
abundant number of primary prognostic factor studies are
published each year, but findings are often inconsistent,
methods heterogeneous and the methodological quality
questionable. Systematic reviews and meta-analyses are
therefore needed to summarise the evidence.
Methods and analysis The reporting of this protocol
adheres to the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols (PRISMA-P) checklist.
We will include retrospective and prospective studies
with a follow-up of at least 3 months reporting patient-
related factors and surgery-related factors for any adult
population. Randomised controlled trials will be included
if they report on prognostic factors for CPSP after lung or
pleural surgery. We will exclude case series, case reports,
literature reviews, studies that do not report results
for lung or pleural surgery separately and studies that
modified the treatment or prognostic factor based on pain
during the observation period. MEDLINE, Scopus, Web of
Science, Embase, Cochrane, CINAHL, Google Scholar and
relevant literature reviews will be searched. Independent
pairs of two reviewers will assess studies in two stages
based on the PICOTS criteria. We will use the Quality in
Prognostic Studies tool for the quality assessment and
the CHARMS-PF checklist for the data extraction of the
included studies. The analyses will all be conducted
separately for each identified prognostic factor. We will
analyse adjusted and unadjusted estimated measures
separately. When possible, evidence will be summarised
with a meta-analysis and otherwise narratively. We
will quantify heterogeneity by calculating the Q and I2
statistics. The heterogeneity will be further explored with
meta-regression and subgroup analyses based on clinical
knowledge. The quality of the evidence obtained will be
evaluated according to the Grades of Recommendation
Assessment, Development and Evaluation guideline 28.
Ethics and dissemination Ethical approval will not be
necessary, as all data are already in the public domain.
Results will be published in a peer-reviewed scientific
journal.
PROSPERO registration number CRD42021227888.

Strengths and limitations of this study
►► This systematic review and meta-analysis will be

the first to systematically identify all prognostic factors for chronic post-surgical pain after lung or pleural surgery and to summarise the evidence.
►► To ensure methodological quality, this systematic review and meta-analysis will be conducted following
the PROGnosis RESearch Strategy guide for prognostic factor meta-analyses.
►► Heterogeneity in the methods, the study populations
and the reported outcomes of the included studies
together with unexplained heterogeneity, will result
in some level of uncertainty in our conclusions.

INTRODUCTION
Lung or pleural surgery is performed for a
variety of diseases or injuries, such as lung
cancer, cancer of the pleura, lung emphysema, lung transplantation and abscess after
trauma or pleurodesis for recurrent pneumothorces. The thorax can be surgically
accessed with a regular thoracotomy or with
less invasive video-
assisted thoracic surgery
(VATS). Thoracic surgery is associated with
chronic post-surgical pain (CPSP), which is
classified as any pain related to the surgery
and persisting for 3 months or longer after
surgery.1 2 CPSP often starts as a hard to
control and acute post-
surgical pain which
later transitions into a persisting chronic
pain.3 The pain is regularly localised at the
chest wall and related to the area of surgery,
but it can also be referred to a different area.
It commonly increases with movement and
often has a neuropathic component.4 5 CPSP
has been observed in as many as 57% and 47%
of the patients 3 and 6 months after thoracic
surgery, respectively.6 Hence, thoracic
surgery has the highest incidence of CPSP
among all types of surgery.3 7 VATS is assumed
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OBJECTIVES
Our main goal is to carry out a systematic overview of the
evidence regarding prognostic factors for CPSP after lung
or pleural surgery. Our objectives are to identify, describe
and appraise all studies reporting prognostic factors for
CPSP after lung or pleural surgery, and summarise the
evidence for each prognostic factor, either quantitatively
with a meta-
analysis or qualitatively by describing the
evidence as a narrative, as appropriate.
2

Table 1
criteria

Summary table of the PICOTS used as selection

Population
Index
prognostic
factors

Any population of adult participants (18
years or older) who have had any type of
lung or pleural surgery.
Pre-identified prognostic factors:
Preoperative pain, postoperative pain,
pain catastrophising score, age, gender,
body mass index, diabetes mellitus,
exercise tolerance, malignant diseases,
chemotherapy, radiation therapy, surgery
duration, anaesthesia technique and surgical
technique. Any newly identified prognostic
factors will also be considered.

Comparator
prognostic
factors

Because we will systematically identify
all prognostic factors and summarise the
evidence, no comparator prognostic factors
are involved.

Outcome

Chronic post-surgical pain as outcome.

Timing
Setting

Follow-up of 3 months or more.
Any healthcare setting.

METHODS AND ANALYSIS
The reporting of this protocol adheres to the Preferred
Reporting Items for Systematic Review and Meta-Analysis
Protocols (PRISMA-P) checklist.30 31 It has been registered
at the International Prospective Register of Systematic
Reviews. For the project design we used guidance from
the PROGnosis RESearch Strategy group, and specifically
the guide for systematic reviews and meta-analyses for
prognostic factor studies.26 The results of the systematic
review will be reported following the PRISMA checklist.32
Study eligibility
We will include retrospective and prospective studies
naming and evaluating a prognostic factor relating to
chronic pain following lung or pleural surgery with at
least 3 months of follow-up. Randomised controlled trials
will be included if they report on prognostic factors for
chronic pain after lung or pleural surgery. Case series,
case studies, literature reviews, studies that do not report
results for lung or pleural surgery separately and studies
that modified the treatment or prognostic factor based
on pain during the observation period will be excluded.
We will use the PICOTS system as selection criteria for
studies with the appropriate study type. (table 1). The
PICOTS system is an updated modification for prognostic
studies of the traditional PICO system, incorporating
‘timing (T)’ and ‘setting (S)’.33 34 Timing includes at what
time points the prognostic factors are being measured
and setting includes the intended setting, such as primary
or secondary care.26
Search strategy
We will search key health and medical databases
(MEDLINE, Scopus, Web of Science, Embase, Cochrane,
CINAHL and Google Scholar) for peer-reviewed literature
Clephas PRD, et al. BMJ Open 2021;11:e051554. doi:10.1136/bmjopen-2021-051554
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to be less painful compared with a regular thoracotomy
because it is less invasive, however, incidence and severity
of CPSP have been reported to be similar.8 CPSP after
thoracic surgery has been associated with a lower overall
quality of life,9–13 and chronic pain is associated with an
increased utilisation of healthcare, increased absenteeism
and decreased work-related effectiveness.14–16 The direct
health-related costs of chronic pain have been reported
to be US$11 846 annually,17 and the indirect work-related
costs have been reported to be US$29 617 annually.17
The burden of CPSP for cancer survivors is also increasingly recognised, given the progress that has been made
in cancer treatment.18 Furthermore, CPSP often results
in the long-
term use of pain medication, particularly
opioids, which contributes to overuse, misuse and addiction of opioids,19–21 and thoracic surgery as an independent factor has also been associated with prolonged
postoperative opioid use.22 Thus, CPSP has significant
health and economic related consequences and is a problematic complication. Evidence for prognostic factors can
contribute to improved clinical decision-making and individualised risk prediction by healthcare providers. A prognostic factor is defined as any variable affecting the risk of
a particular health outcome and should be evaluated in a
representative sample of patients assembled at the same
time point in the course of their disease.23 24 It can also
contribute to the development of treatment strategies
by identifying modifiable prognostic factors as targets.25
This systematic review and meta-analysis will focus on all
relevant reported prognostic factors for CPSP after lung
or pleural surgery. There are two main categories we are
interested in: Patient-related factors and surgery-related
factors. A great number of primary prognostic factor
studies are being published each year, however, they are
often methodologically poor, their findings inconsistent
and the methods heterogeneous.23 Therefore, systematic reviews and meta-analyses are needed to summarise
the evidence.23 26 Other systematic reviews have been
done regarding the incidence, severity and therapeutic
interventions of chronic pain after thoracic surgery.6 27 28
Another review has been done regarding the pathogenic
mechanisms and strategies for prevention of chronic
pain after thoracotomy.29 To our knowledge, a systematic
review and meta-
analysis regarding prognostic factors
for CPSP after lung or pleural surgery has not yet been
performed.
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Study screening
Independent pairs of two reviewers will assess studies in
two stages based on the inclusion and exclusion criteria.
They will screen studies in stage one on title and abstract
and in stage two on the full text. Differences will be
resolved through either a consensus meeting or consultation of a third reviewer in both selection phases. We will
use the PRISMA flowchart to display the study selection
process, including the exclusion reasons of non-eligible
studies.32 Studies retrieved from the searches will be
stored and screened in EndNote V.X9.38 The excluded
studies will be stored in EndNote subgroups for each
exclusion reason. The data that will be extracted from
eligible studies will be stored and managed in Microsoft
Excel V.16.43.
Data extraction
For the data collection process we will use the standardised
CHARMS-PF checklist,26 which is based on the CHARMS
checklist,34 but adjusted for prognostic factor studies. It
has nine domains, covering everything needed to reliably pool data: source of data, participants, outcomes
to be predicted, prognostic factors, sample size, missing
data, analysis, results and interpretation and discussion.
Specific attention will be paid to the following data items:
Reported factors of prognostic interest, definition and
measurement of outcomes, adjusted and unadjusted
outcomes, adjustment factors, regression methods and
timing. When multiple follow-up time points are available,
we will use a time point of at least 3 months that is closest
to 3 months. If only the mean follow-up or the range of
follow-up is reported, it needs to be at least 3 months. Any
additional information deemed necessary will be added
in a bespoke Excel data extraction file. If information in
a study is missing or unclear, the primary study authors
Clephas PRD, et al. BMJ Open 2021;11:e051554. doi:10.1136/bmjopen-2021-051554

will be contacted with the request to provide additional
information. We will consider the study with the biggest
sample size or the most recent, as appropriate, as the
most relevant one when there are multiple publications
with the same or overlapping participant data.
Risk of bias in individual studies
The quality of included studies will be assessed by two
independent reviewers with the Quality in Prognostic
Studies tool.39 This tool contains six domains: Study
participation, study attrition, prognostic factor measurement, outcome measurement, study covariates and statistical analysis and reporting. Each domain is rated as low,
moderate or high risk of bias. If information in a study is
missing or unclear, the authors will be contacted with the
request to provide additional information. Differences
between the two reviewers will be resolved through either
a consensus meeting or consultation of a third reviewer.
Data synthesis
The characteristics of the identified prognostic factors will
be summarised in a table. For the quantitative synthesis
we will obtain ORs, risk ratios (RRs) and HRs as measures
of association as reported in each included study. The
mean difference will also be considered as an appropriate
measure of association for continuous prognostic factors.
Adjusted and unadjusted estimates for each factor will be
considered and analysed separately. The OR, RR and HR
will also be considered separately. A meta-analysis will be
performed for each prognostic factor when reported by at
least five studies with similar measures of association.26 40
In cases where either the measure (OR, RR or HR), or
its SE are not reported, where possible we will estimate
them from any available data in the included study, such
as confidence intervals, Kaplan-Meier curves, logrank test
p values or other as appropriate.41–44 We will explore any
differences between the reported and estimated measures
through a sensitivity analysis. We will also include a sensitivity analysis when there is heterogeneity between studies
in how chronic pain is defined. For pooling the data, we
will use the DerSimonian and Laird random effects model
to account for expected between study heterogeneity.45 46
We will include a 95% prediction interval in addition to
the 95% CI for the pooled measures.46 Heterogeneity
between studies will be assessed for each meta-analysis by
visually inspecting forest plots and by calculating the Q
statistic and the I2 statistic.47 We will perform a univariable meta-
regression for each continuous prognostic
factor reported by 10 or more studies. All analyses will be
performed with the metafor package in the latest version
of R and RStudio. When quantitative synthesis is not
possible, we will summarise the evidence narratively.
Subgroup analyses
We will perform subgroup analyses where possible to
further explore the heterogeneity. Based on clinical
knowledge, the following subgroups will be investigated:
Malignant diseases, regional anaesthesia (particularly
3
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from inception of each database until most-recent available study on the date of conducting our final search.
Screening of studies will start as soon as possible, and we
aim that the last search date will not be longer than 12
months from the publication date of the final review.
The systematic search will be built by an experienced
information scientist and will be adapted to fit each
information source.35 The reporting and retrieval of
prognostic factors is generally known to be poor, with no
specialised filters available. Hence a broad search will be
employed using the most recent prognostic strategies,
offering a high sensitivity at the cost of a lower specificity.36 We will use no restrictions on language, study
status or time of publication. If translation is necessary, we
will ask a colleague who is fluent in that language to translate. When this is not possible, we will use the Cochrane
task exchange service or Google Translate.37 The search
strategy is included in online supplemental file 1, with the
adaptations for each database. Because of potential limitations of the electronic search strategy, we will supplement
our search with reference searches of relevant literature
studies.
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Publication bias
Funnel plots will be used to assess potential publication
bias for factors of prognostic interest that are reported by
10 or more studies.48 Funnel plots suffer from low power
and this is more problematic for observational studies
(as are studies of prognosis) where there is additionally
increased heterogeneity. To statistically test the asymmetry of the funnel plots we will use the Harbord test,49
and any findings will be interpreted with caution.
Rating of evidence
The evidence and inferences will be evaluated according
to the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) guidelines (GRADE
guideline 28) for assessing the evidence from prognostic
factors.50 It contains five domains: Risk of bias, inconsistency, imprecision, indirectness and publication bias.
Contributors PRDC designed and wrote the protocol in close collaboration with
SEH. MH and PMS provided the idea of the topic. MT and SEH contributed to the
design of the statistical methods. CSG contributed to finding the a priori prognostic
factors. MH and MK coordinated the whole process. All authors read, provided
feedback and approved the final manuscript.
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Supplement 1
Embase
('chronic pain'/exp OR (((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) NEAR/6 (pain* OR
discomfort* OR complaint*)):ti,ab,kw)) AND ('postoperative pain'/exp OR (((postoperative OR
posttreatment OR postsurg*) NEAR/6 (pain* OR analgesi*)) OR ((post OR after OR follow*) NEAR/3
(surg* OR operat* OR treat* OR resect* OR transplant*) NEAR/6 (pain* OR analgesi*)) OR ((post*
NEAR/1 pain*)) OR pain-relief-after OR ((post-extraction OR postextraction OR amputat* OR
mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR thoracostomy OR thoracotomy
OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy OR bronchoscopy OR
pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR postmediastinoscop*
OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR postthoracostom* OR
postthoracotom* OR postthoracocentesis OR postthymectom* OR posttracheostom* OR
posttracheotom* OR postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR
postesophagectom* OR postoesophagectom* OR postlobectom*) NEAR/6 (pain* OR discomfort OR
analgesi*))):ti,ab,kw) AND (('thorax surgery'/exp NOT 'heart surgery'/exp) OR 'lung tumor'/exp/dm_su
OR (((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest
OR pleura*) NEAR/6 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR
thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom*
OR tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR
esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) NEAR/6 (transplant* OR
graft*)) OR ((esophag* OR oesophag*) NEAR/6 (anastom* OR transect* OR dilat* OR
reconstruct*))):ti,ab,kw) NOT [conference abstract]/lim NOT ([animals]/lim NOT [humans]/lim)

Medline
(Chronic Pain/ OR (((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) ADJ6 (pain* OR discomfort*
OR complaint*)).ti,ab,kf)) AND (Pain, Postoperative/ OR (((postoperative OR posttreatment OR
postsurg*) ADJ6 (pain* OR analgesi*)) OR ((post OR after OR follow*) ADJ3 (surg* OR operat* OR treat*
OR resect* OR transplant*) ADJ6 (pain* OR analgesi*)) OR ((post* ADJ1 pain*)) OR pain-relief-after OR
((post-extraction OR postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty
OR thoracoscopy OR thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR
tracheostomy OR tracheotomy OR bronchoscopy OR pneumonolysis OR pneumonectomy OR
esophagectomy OR oesophagectomy OR postmediastinoscop* OR poststernotom* OR
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR
postoesophagectom* OR postlobectom*) ADJ6 (pain* OR discomfort OR analgesi*))).ti,ab,kf) AND
(Thoracic Surgery/ OR (exp Thoracic Surgical Procedures/ NOT exp Cardiac Surgical Procedures/ ) OR
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Lung Neoplasms/su OR (((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib
OR thym* OR chest OR pleura*) ADJ6 (surg* OR operat* OR resect*)) OR mediastinoscop* OR
sternotom* OR thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis
OR thymectom* OR tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR
pneumonectom* OR esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR
poststernotom* OR postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom*
OR postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) ADJ6 (transplant* OR
graft*)) OR ((esophag* OR oesophag*) ADJ6 (anastom* OR transect* OR dilat* OR
reconstruct*))).ti,ab,kf) NOT (exp animals/ NOT humans/)

Web of Science
TS=(((((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR longstanding OR
long-standing OR longlasting OR long-lasting OR phantom) NEAR/5 (pain* OR discomfort* OR
complaint*)))) AND ((((postoperative OR posttreatment OR postsurg*) NEAR/5 (pain* OR analgesi*)) OR
((post OR after OR follow*) NEAR/2 (surg* OR operat* OR treat* OR resect* OR transplant*) NEAR/5
(pain* OR analgesi*)) OR ((post* NEAR/1 pain*)) OR pain-relief-after OR ((post-extraction OR
postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR
thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy
OR bronchoscopy OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) NEAR/5
(pain* OR discomfort OR analgesi*)))) AND ((((thora* OR lung OR pulmonary OR esophag* OR
oesophag* OR trachea* OR rib OR thym* OR chest OR pleura*) NEAR/5 (surg* OR operat* OR resect*))
OR mediastinoscop* OR sternotom* OR thoracoplast* OR thoracoscop* OR thoracostom* OR
thoracotom* OR thoracocentesis OR thymectom* OR tracheostom* OR tracheotom* OR bronchoscop*
OR pneumonolysis OR pneumonectom* OR esophagectom* OR oesophagectom* OR lobectom* OR
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom* OR ((lung OR
pulmonary OR thym*) NEAR/5 (transplant* OR graft*)) OR ((esophag* OR oesophag*) NEAR/5
(anastom* OR transect* OR dilat* OR reconstruct*))))) AND DT=(article)

Cochrane
((((chronic* OR constant* OR continu* OR persist* OR longterm OR long NEXT term OR longstanding OR
long NEXT standing OR longlasting OR long NEXT lasting OR phantom) NEAR/6 (pain* OR discomfort* OR
complaint*)):ti,ab)) AND ((((postoperative OR posttreatment OR postsurg*) NEAR/6 (pain* OR
analgesi*)) OR ((post OR after OR follow*) NEAR/3 (surg* OR operat* OR treat* OR resect* OR
transplant*) NEAR/6 (pain* OR analgesi*)) OR ((post* NEAR/1 pain*)) OR pain NEXT relief NEXT after OR
((post NEXT extraction OR postextraction OR amputat* OR mediastinoscopy OR sternotomy OR
thoracoplasty OR thoracoscopy OR thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy
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OR tracheostomy OR tracheotomy OR bronchoscopy OR pneumonolysis OR pneumonectomy OR
esophagectomy OR oesophagectomy OR postmediastinoscop* OR poststernotom* OR
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR
postoesophagectom* OR postlobectom*) NEAR/6 (pain* OR discomfort OR analgesi*))):ti,ab) AND
((((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest
OR pleura*) NEAR/6 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR
thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom*
OR tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR
esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) NEAR/6 (transplant* OR
graft*)) OR ((esophag* OR oesophag*) NEAR/6 (anastom* OR transect* OR dilat* OR
reconstruct*))):ti,ab)

CINAHL
(MH Chronic Pain OR TI(((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) N5 (pain* OR discomfort*
OR complaint*))) OR AB(((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) N5 (pain* OR discomfort*
OR complaint*)))) AND (MH Postoperative Pain OR TI(((postoperative OR posttreatment OR postsurg*)
N5 (pain* OR analgesi*)) OR ((post OR after OR follow*) N2 (surg* OR operat* OR treat* OR resect* OR
transplant*) N5 (pain* OR analgesi*)) OR ((post* N1 pain*)) OR pain-relief-after OR ((post-extraction OR
postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR
thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy
OR bronchoscopy OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) N5 (pain*
OR discomfort OR analgesi*))) OR AB(((postoperative OR posttreatment OR postsurg*) N5 (pain* OR
analgesi*)) OR ((post OR after OR follow*) N2 (surg* OR operat* OR treat* OR resect* OR transplant*)
N5 (pain* OR analgesi*)) OR ((post* N1 pain*)) OR pain-relief-after OR ((post-extraction OR
postextraction OR amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR
thoracostomy OR thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy
OR bronchoscopy OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) N5 (pain*
OR discomfort OR analgesi*)))) AND ((MH "Thoracic Surgery+" NOT MH "Heart Surgery+" ) OR
TI(((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest
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OR pleura*) N5 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR thoracoplast*
OR thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom* OR
tracheostom* OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR
esophagectom* OR oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR
postthoracoplast* OR postthoracoscop* OR postthoracostom* OR postthoracotom* OR
postthoracocentesis OR postthymectom* OR posttracheostom* OR posttracheotom* OR
postbronchoscop* OR postpneumonolysis OR postpneumonectom* OR postesophagectom* OR
postoesophagectom* OR postlobectom* OR ((lung OR pulmonary OR thym*) N5 (transplant* OR graft*))
OR ((esophag* OR oesophag*) N5 (anastom* OR transect* OR dilat* OR reconstruct*))) OR AB(((thora*
OR lung OR pulmonary OR esophag* OR oesophag* OR trachea* OR rib OR thym* OR chest OR pleura*)
N5 (surg* OR operat* OR resect*)) OR mediastinoscop* OR sternotom* OR thoracoplast* OR
thoracoscop* OR thoracostom* OR thoracotom* OR thoracocentesis OR thymectom* OR tracheostom*
OR tracheotom* OR bronchoscop* OR pneumonolysis OR pneumonectom* OR esophagectom* OR
oesophagectom* OR lobectom* OR postmediastinoscop* OR poststernotom* OR postthoracoplast* OR
postthoracoscop* OR postthoracostom* OR postthoracotom* OR postthoracocentesis OR
postthymectom* OR posttracheostom* OR posttracheotom* OR postbronchoscop* OR
postpneumonolysis OR postpneumonectom* OR postesophagectom* OR postoesophagectom* OR
postlobectom* OR ((lung OR pulmonary OR thym*) N5 (transplant* OR graft*)) OR ((esophag* OR
oesophag*) N5 (anastom* OR transect* OR dilat* OR reconstruct*)))) NOT (MH animals+ NOT MH
humans)

Scopus
TITLE-ABS-KEY(((((chronic* OR constant* OR continu* OR persist* OR longterm OR long-term OR
longstanding OR long-standing OR longlasting OR long-lasting OR phantom) W/5 (pain* OR discomfort*
OR complaint*)))) AND ((((postoperative OR posttreatment OR postsurg*) W/5 (pain* OR analgesi*)) OR
((post OR after OR follow*) W/2 (surg* OR operat* OR treat* OR resect* OR transplant*) W/5 (pain* OR
analgesi*)) OR ((post* W/1 pain*)) OR pain-relief-after OR ((post-extraction OR postextraction OR
amputat* OR mediastinoscopy OR sternotomy OR thoracoplasty OR thoracoscopy OR thoracostomy OR
thoracotomy OR thoracocentesis OR thymectomy OR tracheostomy OR tracheotomy OR bronchoscopy
OR pneumonolysis OR pneumonectomy OR esophagectomy OR oesophagectomy OR
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom*) W/5 (pain*
OR discomfort OR analgesi*)))) AND ((((thora* OR lung OR pulmonary OR esophag* OR oesophag* OR
trachea* OR rib OR thym* OR chest OR pleura*) W/5 (surg* OR operat* OR resect*)) OR
mediastinoscop* OR sternotom* OR thoracoplast* OR thoracoscop* OR thoracostom* OR thoracotom*
OR thoracocentesis OR thymectom* OR tracheostom* OR tracheotom* OR bronchoscop* OR
pneumonolysis OR pneumonectom* OR esophagectom* OR oesophagectom* OR lobectom* OR
postmediastinoscop* OR poststernotom* OR postthoracoplast* OR postthoracoscop* OR
postthoracostom* OR postthoracotom* OR postthoracocentesis OR postthymectom* OR
posttracheostom* OR posttracheotom* OR postbronchoscop* OR postpneumonolysis OR
postpneumonectom* OR postesophagectom* OR postoesophagectom* OR postlobectom* OR ((lung OR
pulmonary OR thym*) W/5 (transplant* OR graft*)) OR ((esophag* OR oesophag*) W/5 (anastom* OR
transect* OR dilat* OR reconstruct*)))))
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